CINECA IRIS Institutional Research Information System

Positive results of phase 1 studies evaluating lenvatinib in solid tumors including thyroid cancer prompted a phase 2 trial in advanced medullary thyroid carcinoma (MTC).

A Phase 2 Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC)

ELISEI, ROSSELLA;
2015-01-01

Abstract

Positive results of phase 1 studies evaluating lenvatinib in solid tumors including thyroid cancer prompted a phase 2 trial in advanced medullary thyroid carcinoma (MTC).
2015
Schlumberger, Martin; Jarzab, Barbara; Cabanillas, Maria E; Robinson, Bruce G; Pacini, Furio; Ball, Douglas W; Mccaffrey, Judith C; Newbold, Katie L; Allison, Roger; Martins, Renato G; Licitra, Lisa; Shah, Manisha H; Bodenner, Donald; Elisei, Rossella; Burmeister, Lynn; Funahashi, Yasuhiro; Ren, Min; O'Brien, James P; Sherman, Steven I.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/756261
Citazioni
  • ???jsp.display-item.citation.pmc??? 68
  • Scopus 179
  • ???jsp.display-item.citation.isi??? 154
social impact